ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
University Hospital Düsseldorf at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University Hospital Düsseldorf takes part in 3 sessions at ESMO 2026 in Madrid. Its work covers treatment and outcomes in bile duct and kidney cancers, as well as blood disorders, including molecular testing in IDH1-mutated bile duct cancer treated with ivosidenib.
| Organization | ESMO 2026 Attendance |
|---|---|
University Hospital Düsseldorf Düsseldorf, Germany | |
Teaching hospital of the medical faculty of Heinrich Heine University Düsseldorf, in Düsseldorf, Germany. | Poster Fri Oct 23 13:00–15:00 Molecular testing and clinical outcomes of German patients with IDH1 mutated cholangiocarcinoma treated with ivosidenib: Initial results from the phase 3b ProvIDHe study Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 Talk Sat Oct 24 16:50–17:10 Therapy-related myelodysplastic syndrome Haematological malignancies |
Find decision makers at University Hospital Düsseldorf
Tell us what you sell and we’ll find the people at University Hospital Düsseldorf most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction